PMCPA Case Library

Over 2,000+ real adjudications. Browse free — subscribe to search by company, clause and case reference.

Search by company, clause, case ref…🔒
Filter by clause…🔒
Filter by company…🔒

1,914 cases  ·  Unlock search, clause & company filters ↓

2005
year
AUTH/1745/7/05 Abbott Clause 2 ⭐ Case of the Week

Abbott: media report of gay bar visit with consultant led to hospitality complaint (Appeal Board: no breach)

The Sun alleged Abbott reps attended a Glasgow gay bar with a hospital consultant. Panel found hospitality/Clause 2 breaches, but…

2010
year
AUTH/2363/10/10 Merck Sharp & Dohme

AUTH/2363/10/10: General Practitioner v Merck Sharp & Dohme (Andropause website) — No breach (outwith scope)

Complaint about MSD’s “Andropause” website. PMCPA concluded the matter was outwith the scope of the ABPI Code; no breach was…

2012
year
AUTH/2491/3/12 Roche Products

AUTH/2491/3/12: Member of the public v Roche — Conduct of a clinical trial (out of scope; no breach)

PMCPA case AUTH/2491/3/12 (Member of the public v Roche) about conduct of a clinical trial. The matter was ruled outside…

2018
year
AUTH/3062/8/18 Sanofi Clause 7.2 Clause 7.3

Sanofi Toujeo leavepiece: BRIGHT study titration-phase hypoglycaemia data given disproportionate emphasis

A Toujeo promotional leavepiece highlighted favourable 0–12 week hypoglycaemia results vs degludec with prominent graphics, while 24‑week comparable outcomes were…

2016
year
AUTH/2894/11/16 Mitsubishi Tanabe

AUTH/2894/11/16: Director v Mitsubishi Tanabe — Clinical trial disclosure (BindRen) (No breach / Outwith scope)

PMCPA case AUTH/2894/11/16 (Director v Mitsubishi Tanabe) concerning clinical trial disclosure for BindRen. The case outcome was no breach and…

2019
year
AUTH/3244/9/19 Leo Pharma Clause 16.3 Clause 9.1 ⭐ Case of the Week

Leo Pharma: MSL activity deemed promotional, triggering ABPI exam requirement (AUTH/3244/9/19)

Anonymous employee complaint about Leo’s dermatology MSLs. Panel found some MSL speaker-meeting activity was promotional, so MSLs should have taken…

2020
year
AUTH/3329/3/20 Boehringer Ingelheim

Boehringer Ingelheim: Pradaxa website landing page alleged public promotion (AUTH/3329/3/20) – No breach

Complaint alleged Pradaxa.co.uk encouraged the public to seek more info about a POM. Panel found the public-facing section was factual…

2020
year
AUTH/3319/3/20 AstraZeneca

AstraZeneca: Symbicort COPD formulary guide prescribing information challenged as out of date (AUTH/3319/3/20)

A UK health professional alleged Symbicort COPD formulary material omitted a newer SPC warning. PMCPA found the warning related to…

2019
year
AUTH/3228/7/19 Ipsen

Merz v Ipsen: Dysport ‘long-lasting effect’ campaign found misleading on appeal (AUTH/3228/7/19)

After inter-company dialogue, Ipsen’s Dysport messaging implying superior duration of effect was found misleading and not supportive of rational use.…

2019
year
AUTH/3193/4/19 Novartis Pharmaceuticals UK Clause 9

Novartis heart failure therapy review service: complaint about third-party email implying ‘client product/therapy priorities’ (No breach)

Anonymous group alleged a third-party email showed commercial bias in Novartis-sponsored heart failure therapy reviews. Panel and Appeal Board had…

2020
year
AUTH/3363/6/20 GlaxoSmithKline ⭐ Case of the Week

AUTH/3363/6/20: GSK Anoro Ellipta public website page – no breach (reference information and certification upheld)

A UK health professional alleged GSK’s public Anoro Ellipta webpage promoted a POM and encouraged requests for treatment, and questioned…

2020
year
AUTH/3390/9/20 Janssen Clause 3.1 Clause 9.1

Janssen: UK employee’s LinkedIn post about unlicensed Covid-19 vaccine candidate ruled pre-authorisation promotion (AUTH/3390/9/20)

A Janssen UK employee reposted/commented on a US exec’s LinkedIn update about a Covid-19 vaccine candidate entering Phase 3. Panel…

2020
year
AUTH/3335/4/20 Britannia Clause 1 Clause 9

Britannia advisory boards for Apo-Go: poor governance and record-keeping led to Clause 9.1 and 23.1 breaches

Ex-employee alleged Apo-Go advisory boards were promotional. Panel found high standards breach (9.1). On appeal, poor documentation, SOP deviations and…

2020
year
AUTH/3438/12/20 Pfizer Clause 2 Clause 7.9 Clause 9.1

Pfizer: Senior employee’s LinkedIn post linking to BBC ‘vaccine judged safe’ headline breached ABPI Code

A senior Pfizer UK employee posted a proud LinkedIn message linking to a BBC article with an unqualified “safe” headline…

2021
year
AUTH/3468/2/21 Sanofi Clause 14 Clause 15 Clause 9

Sanofi breached ABPI Code after uncertified internal email to salesforce about Toujeo patient materials and digital campaigns (AUTH/3468/2/21)

An internal salesforce email mixing patient booklet availability with digital campaign screenshots wasn’t itself improper, but it was treated as…

2020
year
AUTH/3414/11/20 Novartis Pharmaceuticals UK Clause 26 Clause 28 Clause 3 ⭐ Case of the Week

Novartis: corporate webpage pipeline table ruled to promote POMs to the public and an unlicensed medicine (AUTH/3414/11/20)

Novartis’ corporate webpage listed pipeline products with indications and trial details. PMCPA ruled it promoted two licensed POMs to the…

2021
year
AUTH/3465/2/21 Vifor Pharma

AUTH/3465/2/21: Complainant v Vifor — Venofer symposium and alleged off-licence promotion (No breach)

Anonymous UK health professional alleged a Vifor-sponsored PIVOTAL sub-analysis symposium promoted off-licence Venofer use. Panel found PIVOTAL dosing aligned with…

2021
year
AUTH/3498/3/21 Leo Clause 27 Clause 7 Clause 9

LEO Pharma: late and incomplete disclosure of patient organisation support (AUTH/3498/3/21)

Ex-employee alleged errors/omissions in LEO’s patient organisation support list. PMCPA found late disclosure of 2019 payments and an omitted donation;…

2020
year
AUTH/3411/10/20 AstraZeneca Clause 10 Clause 20 Clause 3

Daiichi Sankyo & AstraZeneca: UK employees’ LinkedIn ‘likes’ brought US trial post into UK Code scope (AUTH/3411/10/20, AUTH/3412/10/20)

UK employees ‘liked’ a US LinkedIn post linking to an Enhertu Phase 3 trial press release. Panel said the ‘likes’…

2020
year
AUTH/3436/12/20 Janssen Clause 2 Clause 9.1

Janssen: Stelara homecare service ran for 28 months without oversight, triggering Clause 2 and public reprimand (AUTH/3436/12/20)

Janssen admitted it failed to oversee a nurse-led Stelara homecare service that continued after “termination”, with missing contracts, inadequate vendor…

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Filter by any clause or company

Members can instantly filter all 2,000+ cases by any of the 154 PMCPA clauses and 291 pharmaceutical companies — plus get video walkthroughs, expert podcasts and CPD certificates for every case.

154
Clauses to filter by
291
Companies to filter by
2,000+
Searchable cases
See plans from £299/year Sign in
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training